The aim of the study was to assess constant potential levels (CP level) in patients with vibration disease (VD) in combination with metabolic disorders. Methods. Measurements were taken in three gorups: Group I (n = 94) - patients with VD, Group II (n = 42) - patients with VD and metabolic syndrome (MS), Group III (n = 31) - patients with VD and Type 2 diabetes (DM2), Group IV (n = 14) - patients with DM2 and V (n = 50) - reference group. Data were analyzed using Shapiro-Wilk, Mann-Whitney tests and discriminant analysis. Results. In groups I-IV, the percentage of individuals with altered neuroenergetic activity was higher than in the experimental group (p = 0.001; 0.003; 0.01; 0.009, respectively). CP level in group I prevailed in the central, in group II - in the left central, right temporal, in group III - in the left central, central, in group IV - in the right frontal, central, and left parietal leads when compared with group V at p < 0.01. CP level decrease in the anterior cortex (frontal, temporal: 16.6 (15-18) mV, 14.7 (12-17) mV, 17.6 (16-20) mV respectively), and its amplification in the posterior (Central, parietal: 20.4 (16-25) mV, 18.2 (14-20) mV, 23.3 (17-28) mV respectively) at p < 0.01 was diagnosed in patients of groups II-IV. As a result of discriminative analysis, two signs were identified in groups I and III: the values of CP level indicators in the left temporal and right central leads. Conclusions. Disorders of neuroenergy exchange in patients with VD in combination with MS and DM2 are manifested by an increase in CP level in the centrotemporal areas, with DM2- in the frontal-central-parietal areas. The signs of neuroenergetic mapping in patients with VD, associated with the fact of DM2 presence as a concomitant pathology are: an increase in the CP level in the right central and its decrease in the left temporal leads.